Boston Healthcare develops an implementable strategy for preparing to secure appropriate and consistent coverage, coding, and payment through research with physician stakeholders, Medicare Carrier Medical Directors, and cell collection providers to assure that data captured in the course of the Phase III trial addresses questions likely to arise in the technology assessment process by physicians and payers. Boston Healthcare recommends timing for initiation of other reimbursement activities and tactics to be completed prior to launch.